Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall Street Expectations After 2020 Price Hikes

In a final round of second quarter earnings reports, another Big Pharma giant announced they surpassed earnings expectations after hiking prices on American patients. Bristol-Myers Squibb reported sky-high profits after hiking prices on American patients earlier this year.

The brand name company’s expectation-besting earnings come after it participated in a series of price hikes in the past year, despite the mounting crisis of affordability across the country.

Bristol-Myers Squibb rounds out a list of Big Pharma giants who all reported expectation-besting earnings for the first quarter of 2020 after hiking prices on American patients – AbbVie, Merck, AstraZeneca, Eli Lilly, Sanofi, Pfizer, Amgen, Novartis, and Johnson & Johnson.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.